This study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasibility and value in clinical application.
All adult male patients who are scheduled to undergo prostate biopsy at the Department of Urology, Xiangya Hospital due to clinical suspicion (e.g., elevated PSA, abnormal digital rectal examination, or suspicious lesions on imaging).
Patients whose cardiac, pulmonary, hepatic, renal, and coagulation functions are essentially normal and who are able to tolerate the biopsy procedure.
The patient or their legally authorized representative has signed the written informed consent form.
Patients in the acute infection phase or febrile period.
Patients with severe bleeding tendency conditions who are unable to undergo biopsy.
Patients with any serious concomitant disease that, in the investigator's opinion, may interfere with the study results or increase the patient's risk (e.g., hypertensive crisis; decompensated cardiac insufficiency; severe internal or external hemorrhoids, perianal or rectal lesions, etc.).
The study population consists of adult male patients scheduled for prostate biopsy at Xiangya Hospital's Department of Urology. Participants must be in a generally stable condition to tolerate the procedure and have no significant comorbidities that would interfere with study assessments or pose additional risks.
Other
Cross-sectional
Not listed
Diagnostic accuracy of prostate biopsy specimens
To evaluate the diagnostic accuracy of the novel rapid infrared fluorescence staining technique for prostate biopsy specimens, and to compare it with frozen section.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
